THE PREVALENCE OF TWO GENETIC TRAITS RELATED TO VENOUS THROMBOSIS IN WHITES AND AFRICAN-AMERICANS

This publication has 15 references indexed in Scilit:

• Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease
  Annals of Internal Medicine, 1995
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
  New England Journal of Medicine, 1995
• High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Resistance to Activated Protein C as a Basis for Venous Thrombosis
  New England Journal of Medicine, 1994
• Inherited resistance to activated protein C iscorrected by anticoagulant cofactor activity found to be a property of factorV.
  Proceedings of the National Academy of Sciences, 1994
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
  The Lancet, 1993
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993